Low expression of ZHX2, but not RCBTB2 or RAN, is associated with poor outcome in multiple myeloma-Reference-Cited by-同舟云学术

Low expression of ZHX2, but not RCBTB2 or RAN, is associated with poor outcome in multiple myeloma

Published:2008-04 Issue:2 Volume:141 Page:212-215
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Armellini A.,Sarasquete M. E.,García-Sanz R.,Chillón M. C.,Balanzategui A.,Alcoceba M.,Fuertes M.,López R.,Hernández J. M.,Fernández-Calvo J.,Sierra M.,Megido M.,Orfão A.,Gutiérrez N. C.,González M.,San Miguel J. F.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2007.06956.x/fullpdf

Reference12 articles.

1. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program

2. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma

3. The Ran GTPase: Theme and Variations

4. Genetics and Cytogenetics of Multiple Myeloma

5. Prognostic implications of DNA aneuploidy in 156 untreated multiple myeloma patients

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ZHX2 deficiency enriches hybrid MET cells through regulating E-cadherin expression;Cell Death & Disease;2023-07-17

2. ZHX2 in health and disease;Frontiers in Oncology;2022-11-18

3. Zinc Fingers and Homeobox Family in Cancer: A Double-Edged Sword;International Journal of Molecular Sciences;2022-09-22

4. Attenuated ZHX3 expression is predictive of poor outcome for liver cancer: Indication for personalized therapy;Oncology Letters;2022-05-25

5. ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer;ELIFE;2021